All-In PodcastE65: VC markup dynamics, Russia/US tensions over Ukraine, Altos Labs raises $3B, Stripe mafia & more
Jason Calacanis on vC markups, war risks, longevity bets, and Stripe-Bolt drama unpacked.
In this episode of All-In Podcast, featuring Jason Calacanis and David Sacks, E65: VC markup dynamics, Russia/US tensions over Ukraine, Altos Labs raises $3B, Stripe mafia & more explores vC markups, war risks, longevity bets, and Stripe-Bolt drama unpacked The hosts open with coping strategies for a brutal market downturn and then dive deeply into how venture capital markups work, why down rounds are resisted, and how that distorts startup valuations and behavior.
At a glance
WHAT IT’S REALLY ABOUT
VC markups, war risks, longevity bets, and Stripe-Bolt drama unpacked
- The hosts open with coping strategies for a brutal market downturn and then dive deeply into how venture capital markups work, why down rounds are resisted, and how that distorts startup valuations and behavior.
- They spend substantial time on the Russia–Ukraine crisis, arguing U.S. war talk is historically unprecedented and dangerous, outlining NATO’s eastward expansion, Russia’s security concerns, Europe’s energy dependence, and how economic sanctions and diplomacy could de-escalate.
- They analyze Fed policy, inflation, rate hikes, asset sell‑offs, and supply chain shocks, debating whether the Fed can avoid causing an unnecessary recession and where current conditions create opportunity for disciplined investors.
- Later, they discuss Altos Labs’ $3B longevity bet and whether massive early funding helps or hurts deep-tech innovation, and they close with the Bolt vs. Stripe ‘mafia’ saga as a case study in startup PR, VC behavior, and the importance of backing exceptional founders even at high prices.
IDEAS WORTH REMEMBERING
8 ideasSeparate true investments from short-term trades to avoid emotional mistakes.
Chamath highlights that confusing long-term conviction positions with speculative trades led to his worst decisions; building cash buffers and mentally committing to each as either ‘own forever’ or ‘speculate’ reduces panic selling.
Paper markups in VC are powerful but often misleading signals of real value.
Because funds are judged and raise new capital based on marked-up portfolios, there is strong pressure to avoid down rounds, push valuations higher, and use secondary prices—even though many companies will experience major drawdowns over a 10–12 year path to liquidity.
Founders should optimize for the right capital and valuation, not just the highest mark.
The hosts argue that blindly chasing up rounds to please VCs can backfire; better to accept realistic pricing with committed partners than to sustain inflated valuations that constrain future financing options.
U.S. military intervention in Ukraine would be a radical and risky departure from precedent.
Sacks and Friedberg stress that past U.S. presidents avoided direct war with a nuclear Russia over Hungary, Czechoslovakia, Poland, Georgia, and Crimea; they contend the U.S. has no vital interest in Ukraine that justifies such escalation.
NATO expansion and European energy policy helped create today’s Russia–Ukraine flashpoint.
They trace how NATO’s eastward growth, promises made after the Cold War, and Germany’s decision to abandon nuclear in favor of Russian gas (Nord Stream 2) increased Moscow’s sense of encirclement and limited Europe’s leverage.
Aggressive Fed tightening plus balance-sheet runoff risks overshooting into recession.
With markets already sharply down, wealth effects starting to hit spending, and supply chain issues that rate hikes can’t fix, the group warns that multiple rate increases and $9T of QT could unnecessarily tip the economy into contraction.
Huge early war chests and ‘Monte Carlo’ R&D strategies rarely beat focused, hungry teams.
On Altos Labs’ $3B longevity round, Chamath questions whether spreading vast capital across many parallel bets is as effective as a lean startup pursuing a single, sharp thesis, noting history’s poor record for overfunded, unfocused projects.
For great founders, being a ‘price taker’ often beats over-optimizing on valuation.
Using Bolt as an example, the investors concede that passing over exceptional founders because a round felt ‘too expensive’ was a major mistake; they now lean toward accepting market prices to get into the right companies.
WORDS WORTH SAVING
5 quotesIf I confuse an investment with a trade, I'm done for.
— Chamath Palihapitiya
Paper markups are the lifeblood of the venture industry.
— Chamath Palihapitiya
America has a vital national interest in avoiding war with a nuclear-armed Russia, and we do not have a vital national interest in defending the territorial sovereignty of Ukraine.
— David Sacks
You don't solve these supply chain issues with rate hikes.
— David Sacks
Sometimes it’s like growing great wine. You need a little pain and suffering along the way. And when you have $3 billion, it's the opposite of pain and suffering.
— Chamath Palihapitiya
QUESTIONS ANSWERED IN THIS EPISODE
5 questionsHow can venture funds realistically reform their incentive structures so that taking necessary markdowns and down rounds is not punished when the underlying business is still solid?
The hosts open with coping strategies for a brutal market downturn and then dive deeply into how venture capital markups work, why down rounds are resisted, and how that distorts startup valuations and behavior.
To what extent is NATO’s mission and geographic scope still appropriate, and should the alliance formally renounce adding countries like Ukraine and Georgia to reduce war risk with Russia?
They spend substantial time on the Russia–Ukraine crisis, arguing U.S. war talk is historically unprecedented and dangerous, outlining NATO’s eastward expansion, Russia’s security concerns, Europe’s energy dependence, and how economic sanctions and diplomacy could de-escalate.
What specific indicators should investors watch to distinguish between a temporary market repricing due to rate expectations and the onset of a true demand-driven recession?
They analyze Fed policy, inflation, rate hikes, asset sell‑offs, and supply chain shocks, debating whether the Fed can avoid causing an unnecessary recession and where current conditions create opportunity for disciplined investors.
Is there an optimal way to fund deep-tech and biotech platforms like Altos Labs that balances bold, long-horizon research with the focus and scarcity that usually drives startup execution?
Later, they discuss Altos Labs’ $3B longevity bet and whether massive early funding helps or hurts deep-tech innovation, and they close with the Bolt vs. Stripe ‘mafia’ saga as a case study in startup PR, VC behavior, and the importance of backing exceptional founders even at high prices.
What decision frameworks can VCs and founders adopt to avoid over-fixating on entry price and instead prioritize founder quality, product-market fit, and long-term value creation like in the Bolt case?
EVERY SPOKEN WORD
Install uListen for AI-powered chat & search across the full episode — Get Full Transcript
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome